Incannex Healthcare Inc. financial data

Symbol
IXHL on Nasdaq, IHLXF on OTC
Industry
Pharmaceutical Preparations
Location
401 Docklands Drive, Suite 15, Level 12, Docklands, Victoria, Australia
State of incorporation
Australia
Fiscal year end
June 30
Former names
Incannex Healthcare Ltd (to 11/29/2023)
Latest financial report
Q1 2024 - May 15, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.9M shares
Common Stock, Shares, Outstanding 12.9M shares
Common Stock, Value, Issued 2K USD
Weighted Average Number of Shares Outstanding, Basic 15.9M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 15.9M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.28M USD +99.9%
General and Administrative Expense 4.14M USD +106%
Operating Income (Loss) -7.42M USD -103%
Nonoperating Income (Expense) 1.38M USD +1630%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.03M USD -68.9%
Net Income (Loss) Attributable to Parent -6.03M USD -68.9%
Earnings Per Share, Basic -0.38 USD/shares -72.7%
Earnings Per Share, Diluted -0.38 USD/shares -72.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.31M USD
Assets, Current 16.3M USD
Property, Plant and Equipment, Net 523K USD
Operating Lease, Right-of-Use Asset 408K USD
Assets 17.3M USD
Employee-related Liabilities, Current 315K USD
Accrued Liabilities, Current 1.13M USD
Liabilities, Current 2.86M USD
Operating Lease, Liability, Noncurrent 248K USD
Liabilities 3.11M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.66M USD
Retained Earnings (Accumulated Deficit) -104M USD
Stockholders' Equity Attributable to Parent 14.1M USD -42.7%
Liabilities and Equity 17.3M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 100M shares
Common Stock, Shares, Issued 15.9M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.31M USD -62.6%
Operating Lease, Liability 409K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.85M USD -81.6%
Lessee, Operating Lease, Liability, to be Paid 534K USD
Property, Plant and Equipment, Gross 587K USD
Operating Lease, Liability, Current 161K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 199K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 205K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 125K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 48K USD
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 9.08M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 32K USD
Operating Lease, Payments 61K USD
Additional Paid in Capital 122M USD
Share-based Payment Arrangement, Expense 2.12M USD +298%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares